Literature DB >> 33964416

Lactobacillus rhamnosus GG defense against Salmonella enterica serovar Typhimurium infection through modulation of M1 macrophage polarization.

Bingjie Duan1, Lina Shao1, Ruihan Liu1, Petunia Msuthwana1, Jingtao Hu2, Chunfeng Wang3.   

Abstract

Lactobacillus rhamnosus GG (LGG), a model probiotic strain, plays an important role in immune regulatory activity to prevent and treat intestinal inflammation or diarrhea. However, the effect of the immune modulation of LGG on macrophages to prevent Salmonella infection has not been thoroughly studied. In this study, C57BL/6 mice were pre-administered LGG for 7 days continuously, and then infected with Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium). The results of the in vivo study indicated that LGG could reduce body weight loss, death rate and intestinal inflammatory response caused by S. Typhimurium. LGG also limited S. Typhimurium dissemination to liver and spleen, and thereby protected against infection. In vitro study, we observed that LGG enhanced the phagocytic and bactericidal ability of macrophages and upregulated M1 macrophage characters (e.g. iNOS, NO and IL-12) against S. Typhimurium. In addition, LGG also elevated IL-10 secretion, which was helpful to ameliorate intestinal inflammatory injury caused by S. Typhimurium. In conclusion, LGG could modulate M1 macrophage polarization and offer protective effects against S. Typhimurium infection.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lactobacillus rhamnosus; Macrophage; Polarization; Protective effect; Salmonella Typhimurium

Year:  2021        PMID: 33964416     DOI: 10.1016/j.micpath.2021.104939

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  1 in total

1.  Lactobacillus plantarum RS-09 Induces M1-Type Macrophage Immunity Against Salmonella Typhimurium Challenge via the TLR2/NF-κB Signalling Pathway.

Authors:  Chenpei Zhao; Huan Chen; Hao Liang; Xiaoyu Zhao; Wenli Tang; Maolian Wei; Youzhi Li; Jianlong Zhang; Xin Yu; Guozhong Chen; Hongwei Zhu; Linlin Jiang; Xingxiao Zhang
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.